Cite
HARVARD Citation
Ritzmann, T. et al. (2020). A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups. Pediatric blood & cancer. 67 (9), p. n/a. [Online].